Variation in Outpatient Antibiotic Prescribing in the United States

Overview

Journal Am J Manag Care

Specialty Health Services

Date 2009 Dec 17

PMID 20001167

Citations 18

Authors

Michael A Steinman

Katherine Y Yang

Sepheen C Byron

Judith H Maselli

Ralph Gonzales

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate variation in outpatient antibiotic utilization among US commercial health plans and the implications of this variation for cost and quality.

Study Design And Methods: We measured antibiotic utilization rates among 229 US commercial health plans that participated in the 2005 Healthcare Effectiveness Data and Information Set. Rates were adjusted to account for health plan age and sex distribution. To estimate antibiotic costs, we multiplied utilization data for each drug class by national estimates of intraclass distribution of drugs, duration of therapy, and median average wholesale price.

Results: Antibiotic utilization rates varied markedly among plans, ranging from 0.64 antibiotic fills per member per year (PMPY) at the 5th percentile of plans to 1.08 fills PMPY at the 95th percentile, with a mean of 0.88 (SD +/- 0.15) antibiotic fills PMPY. US census region was the strongest predictor of antibiotic utilization. Antibiotic costs averaged $49 PMPY and ranged from $34 to $63 PMPY among plans at the 5th and 95th percentiles of cost, respectively. If a health plan with 250,000 members at the 90th percentile of antibiotic costs reduced its costs to the 25th percentile, annual drug cost savings would be approximately $4.1 million.

Conclusions: Antibiotic utilization varies substantially among commercial health plans and is not accounted for by differences in the age and sex distribution of plan members. Because reducing rates of antibiotic utilization is likely to lower costs and improve quality, high-utilizing plans may reap considerable rewards from investing in programs to reduce the overuse of antibiotics.

Citing Articles

Declining but Pronounced State-Level Disparities in Prescription Opioid Distribution in the United States.

Madera J, Ruffino A, Feliz A, McCall K, Davis C, Piper B Pharmacy (Basel). 2024; 12(1).

PMID: 38251408 PMC: 10801547. DOI: 10.3390/pharmacy12010014.

A retrospective review of antibiotic use for acute respiratory infections in urgent-care patients.

Childers R, Bisanz B, Vilke G, Brennan J, Cronin A, Castillo E Antimicrob Steward Healthc Epidemiol. 2022; 2(1):e189.

PMID: 36505944 PMC: 9727505. DOI: 10.1017/ash.2022.337.

Antibiotic prescribing trends in the US during the first 11 months of the COVID-19 pandemic.

Desai K, Arora P, Ghanekar S, Johnson K, Harris I Res Social Adm Pharm. 2022; 18(10):3855-3859.

PMID: 35589530 PMC: 9108895. DOI: 10.1016/j.sapharm.2022.05.008.

Association between physician adoption of a new oral anti-diabetic medication and Medicare and Medicaid drug spending.

Metes I, Xue L, Chang C, Huskamp H, Gellad W, Lo-Ciganic W BMC Health Serv Res. 2019; 19(1):703.

PMID: 31619229 PMC: 6794771. DOI: 10.1186/s12913-019-4520-4.

Decreasing trends, and geographical variation in outpatient antibiotic use: a population-based study in Central Denmark.

Kristensen P, Johnsen S, Thomsen R BMC Infect Dis. 2019; 19(1):337.

PMID: 31014280 PMC: 6480614. DOI: 10.1186/s12879-019-3964-9.

References

Cars O, Molstad S, Melander A . Variation in antibiotic use in the European Union. Lancet. 2001; 357(9271):1851-3. DOI: 10.1016/S0140-6736(00)04972-2. View

Lu-Yao G, McLerran D, Wasson J, WENNBERG J . An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. JAMA. 1993; 269(20):2633-6. DOI: 10.1001/jama.269.20.2633. View

Aspinall S, Berlin J, Zhang Y, Metlay J . Facility-level variation in antibiotic prescriptions for veterans with upper respiratory infections. Clin Ther. 2005; 27(2):258-62. DOI: 10.1016/j.clinthera.2005.02.002. View

Poses R, Wigton R, Cebul R, Centor R, Collins M, Fleischli G . Practice variation in the management of pharyngitis: the importance of variability in patients' clinical characteristics and in physicians' responses to them. Med Decis Making. 1993; 13(4):293-301. DOI: 10.1177/0272989X9301300405. View

Goossens H, Ferech M, Vander Stichele R, Elseviers M . Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005; 365(9459):579-87. DOI: 10.1016/S0140-6736(05)17907-0. View

Denys G, Koch K, Dowzicky M . Distribution of resistant gram-positive organisms across the census regions of the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial. Am J Infect Control. 2007; 35(8):521-6. DOI: 10.1016/j.ajic.2006.11.004. View

Gonzales R, Malone D, Maselli J, Sande M . Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis. 2001; 33(6):757-62. DOI: 10.1086/322627. View

Elseviers M, Ferech M, Vander Stichele R, Goossens H . Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf. 2006; 16(1):115-23. DOI: 10.1002/pds.1244. View

Ranji S, Steinman M, Shojania K, Gonzales R . Interventions to reduce unnecessary antibiotic prescribing: a systematic review and quantitative analysis. Med Care. 2008; 46(8):847-62. DOI: 10.1097/MLR.0b013e318178eabd. View

10.

. Geographic variation in penicillin resistance in Streptococcus pneumoniae--selected sites, United States, 1997. MMWR Morb Mortal Wkly Rep. 1999; 48(30):656-61. View

11.

Steinman M, Gonzales R, Linder J, Landefeld C . Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med. 2003; 138(7):525-33. DOI: 10.7326/0003-4819-138-7-200304010-00008. View

12.

Austin D, Kristinsson K, Anderson R . The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci U S A. 1999; 96(3):1152-6. PMC: 15366. DOI: 10.1073/pnas.96.3.1152. View

13.

Goossens H, Ferech M, Coenen S, Stephens P . Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis. 2007; 44(8):1091-5. DOI: 10.1086/512810. View

14.

Whitney C, Farley M, Hadler J, Harrison L, Lexau C, Reingold A . Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2001; 343(26):1917-24. DOI: 10.1056/NEJM200012283432603. View

15.

Smith S, Smith G, Heatlie H, Bashford J, Ashcroft D, Verlander N . Reducing variation in antibacterial prescribing rates for 'cough/cold' and sore throat between 1993 and 2001: regional analyses using the general practice research database. Public Health. 2006; 120(8):752-9. DOI: 10.1016/j.puhe.2006.02.007. View

16.

Coenen S, Ferech M, Haaijer-Ruskamp F, Butler C, Vander Stichele R, Verheij T . European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care. 2007; 16(6):440-5. PMC: 2653179. DOI: 10.1136/qshc.2006.021121. View

17.

OConnor G, Quinton H, Traven N, Ramunno L, Dodds T, Marciniak T . Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project. JAMA. 1999; 281(7):627-33. DOI: 10.1001/jama.281.7.627. View

18.

Linder J, Stafford R . Antibiotic treatment of adults with sore throat by community primary care physicians: a national survey, 1989-1999. JAMA. 2001; 286(10):1181-6. DOI: 10.1001/jama.286.10.1181. View

19.

Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K . The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997; 337(7):441-6. DOI: 10.1056/NEJM199708143370701. View

20.

Zaslavsky A, Hochheimer J, Schneider E, Cleary P, Seidman J, McGlynn E . Impact of sociodemographic case mix on the HEDIS measures of health plan quality. Med Care. 2000; 38(10):981-92. DOI: 10.1097/00005650-200010000-00002. View